Travere Therapeutics, Inc.

ROYAL BANK OF CANADA TVTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

40,630

Value ($000)

1,553

Weight

0.0%

2020 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	1,553	0.0%	40,630	12/31/2025
2025 Q2	8/14/2025	7	0.0%	474	6/30/2025
2025 Q1	11/21/2025	97	0.0%	5,405	3/31/2025
2024 Q4	2/14/2025	166	0.0%	9,518	12/31/2024
2024 Q3	11/14/2024	110	0.0%	7,923	9/30/2024
2024 Q2	11/6/2024	62	0.0%	7,544	6/30/2024
2024 Q1	11/5/2024	28	0.0%	3,558	3/31/2024
2023 Q4	2/14/2024	205	0.0%	22,837	12/31/2023
2023 Q3	11/14/2023	87	0.0%	9,686	9/30/2023
2023 Q2	8/14/2023	117	0.0%	7,655	6/30/2023
2023 Q1	5/15/2023	133	0.0%	5,923	3/31/2023
2022 Q4	2/14/2023	268	0.0%	12,740	12/31/2022
2022 Q3	11/14/2022	80	0.0%	3,249	9/30/2022
2022 Q2	8/15/2022	147	0.0%	6,065	6/30/2022
2022 Q1	5/16/2022	157	0.0%	6,113	3/31/2022
2021 Q4	2/14/2022	405	0.0%	13,038	12/31/2021
2021 Q3	11/15/2021	201	0.0%	8,306	9/30/2021
2021 Q2	8/16/2021	59	0.0%	4,053	6/30/2021
2021 Q1	7/20/2021	43	0.0%	1,742	3/31/2021
2020 Q4	2/16/2021	1	0.0%	51	12/31/2020